Editas Medicine, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-50.2M | $-53.7M | $3.5M | $16.9M |
| FY2017 | $-9.4M | $-11.5M | $2.1M | $23.4M |
| FY2018 | $-45.7M | $-50.5M | $4.8M | $26.6M |
| FY2019 | $-40.7M | $-46.8M | $6.2M | $27.2M |
| FY2020 | $-179.8M | $-187.0M | $7.2M | $23.2M |
| FY2021 | $-163.8M | $-171.8M | $8.0M | $43.4M |
| FY2022 | $-177.3M | $-181.5M | $4.1M | $29.3M |
| FY2023 | $-132.2M | $-136.9M | $4.7M | $19.8M |
| FY2024 | $-210.3M | $-219.1M | $8.8M | $21.4M |
| FY2025 | $-165.2M | $-165.8M | $607.0K | $10.0M |